Stay updated on ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial
Sign up to get notified when there's something new on the ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial page.

Latest updates to the ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial page
- CheckyesterdayChange DetectedThe page has updated the study on the Alleviant System, reducing the number of locations from 90 to 87 and changing the date of the last update. Additionally, the locations have been modified, with some international sites removed.SummaryDifference2%
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check44 days agoChange DetectedThe page has been updated to reflect an increase in study locations from 89 to 90, with new locations added in Indiana, MI, and Spain, while several previous locations in the U.S. have been removed. Additionally, there are updates regarding heavy traffic affecting NLM-NCBI services and a new estimated last update date.SummaryDifference6%
- Check52 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check66 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check73 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference0.3%
Stay in the know with updates to ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial page.